Patients don't choose a country. They choose a procedure, a price band, and a flight they're willing to take — and the country falls out of those three. That's why destination rankings that treat health tourism as one market are close to useless for a clinic owner. A dental patient in Vienna and a bariatric patient in Manchester are looking at completely different maps.
What follows is a procedure-level read on the four destinations that shape most of the enquiries we see, and what each one means if you're competing in — or against — them.
Read all of it as directional patterns, not audited statistics. Health-tourism volumes are poorly measured everywhere: national figures usually count anyone who ticked "medical" at a border, clinic-reported numbers are marketing, and the aggregators publishing "market size" reports are selling something. Treat any precise-looking number in this industry with suspicion, including from us. What is knowable is the shape of demand — which procedures generate enquiries into which destinations, how price bands compare, what patients ask before they commit, and where competition is thickening. That is what this report covers.
Türkiye: the volume market, no longer winning on price alone
Türkiye — Istanbul and Antalya above all — remains the default destination for hair restoration, dental, and a large share of aesthetic surgery from Western Europe and the Gulf. The infrastructure advantage is real and hard to replicate: dense clusters of accredited hospitals, a mature package economy of hotels, transfers, and translators, and flight connectivity that puts most of Europe within four hours.
The change worth noticing is that price is no longer the deciding variable inside Türkiye — it's the deciding variable for getting to Türkiye. Once a patient has chosen the country, they are choosing among dozens of clinics whose headline prices sit within a narrow band, and the discriminators become surgeon credentials, revision policy, aftercare, and how the clinic answered their first message. Clinics still competing on being the cheapest option in Istanbul are competing in the one dimension where the market has already bottomed out and where patients have learned to read a low price as a warning.
The second change is patient sophistication. The "transplant-and-fly-home" model is being outcompeted by clinics that offer named surgeons, itemized packages, and a structured follow-up at 3, 6 and 12 months. Enquiries increasingly ask who performs the incisions versus who performs the extractions — a question that did not appear in enquiry text three years ago.
Hungary: dentistry's default, and its ceiling
Budapest and the border towns around Sopron have been the dental capital of Europe for two decades, and the position is stable. The catchment is Austria, Germany, Switzerland, Ireland and the UK; the pitch is a full-mouth rehabilitation or implant case at a fraction of home-market pricing, in an EU jurisdiction, within a two-hour flight and with a two-visit treatment plan that fits around a working life.
Hungary's advantage is regulatory and cultural rather than economic: EU-standard materials and consent processes, familiar recourse, and a patient population that never has to explain the trip to their family. That's why Hungary tends to hold price better than pure cost-arbitrage destinations — it wins the patients who wanted a bargain but not an adventure.
The ceiling is that dentistry is essentially all of it. Attempts to extend the Hungarian brand into aesthetics or orthopaedics have not travelled, and dental patients are structurally two-visit patients with a six-month gap — which makes the calendar, not the marketing, the constraint on a Hungarian clinic's growth.
Portugal: the quiet compounder
Portugal is the destination clinic owners underrate. It isn't the cheapest option for anything, and that's the point. Lisbon, Porto and the Algarve are picking up patients from the UK, France, Germany and the Nordics who priced Türkiye, found it plausible, and then decided they wanted the procedure done somewhere they'd also be comfortable recovering.
The procedures moving there are the ones where the recovery is the trip: dental implantology, aesthetic surgery with a two-week convalescence, fertility, and a growing longevity and diagnostics segment aimed at the resident expatriate population and the people who visit them. Portugal's positioning is not "same procedure, less money" — it's "the price is a discount, the experience isn't", and it converts a patient segment that would never have flown to a cheaper market.
If you are a clinic in a high-cost market wondering how to compete with health tourism, this is the case study. Portugal is not beating Türkiye on Türkiye's terms; it is beating it on a dimension Türkiye doesn't compete on.
Thailand: long-haul, high-consideration, high-value
Bangkok and Phuket are a different business model entirely. A long-haul flight filters out the price-shopper: nobody flies eleven hours to save €400. What arrives instead is a patient with a longer decision cycle, a higher budget, and a procedure serious enough to justify the journey — gender-affirming surgery, complex aesthetic work, orthopaedic and spinal cases, and a well-established cardiac and oncology second-opinion trade.
Thailand's clinics are also the most operationally mature in the category. The large private hospitals have run international patient departments for thirty years, and the standard they set — a named coordinator, an itemized estimate before travel, and a written aftercare plan — is the standard European clinics are now being measured against by patients who have compared both.
The demand shift to watch is the Gulf and Chinese source markets recovering their share, and the growth of longevity and executive-diagnostics packages that bring patients back annually. A returning patient is a fundamentally better business than a one-off surgical case, and Thailand is the market building for that.
Procedure by procedure, in one place
- Hair restoration: Türkiye dominant, competition brutal, differentiation now entirely on surgeon involvement and aftercare rather than graft count or price.
- Dental implants and full-mouth: Hungary for EU-comfort buyers, Türkiye for price-led buyers, Portugal taking the middle — patients who want a discount without a compromise narrative.
- Aesthetic surgery: the most fragmented category. Türkiye on volume, Portugal and Spain on recovery experience, Thailand on complex and revision work.
- Bariatric: Türkiye still the price anchor, but this is the category where outcome data and follow-up structure move enquiries the most — patients have read the failure stories.
- Fertility: a legal-jurisdiction market before it is a price market. Patients travel to where the treatment is permitted; price is a second-order concern.
- Orthopaedics and spine: long-haul-tolerant, insurer-adjacent, and the category where accreditation and named consultants matter more than anything else on your page.
On GetClinic: every clinic is verified before it goes live — licenses, accreditations and doctor credentials checked — and routed leads arrive with the procedure, budget and timeline already stated. Analytics then show which source markets and which procedures are actually producing enquiries for your clinic, instead of leaving you to infer a strategy from someone else's market report.
What to do with this
Three moves, in order of how much they'll change your numbers:
- Know which dimension you win on. Price, jurisdiction, experience, or complexity. Pick one and write your treatment pages in that language. Clinics that claim all four convert on none.
- Watch the source market, not the destination. Your competition isn't the clinic down the street — it's the clinic in another country appearing next to you in the same patient's comparison. Track which countries your enquiries come from and price against the alternative that patient is actually considering.
- Build for the returning patient. Every destination above is converging on aftercare, follow-up, and annual programmes, because a second visit costs nothing to acquire. Most clinics still have no follow-up beyond a discharge sheet.
Destination advantages erode. Operational advantages compound. The clinics that will still be here in 2030 are not the ones in the right country — they're the ones that answered fastest, quoted clearest, and gave the patient a reason to come back.